Tamarack Capital Management as of Dec. 31, 2013
Portfolio Holdings for Tamarack Capital Management
Tamarack Capital Management holds 29 positions in its portfolio as reported in the December 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf (SPY) | 21.9 | $92M | 500k | 184.69 | |
| iShares Russell 2000 Index (IWM) | 8.2 | $35M | 300k | 115.36 | |
| Alkermes (ALKS) | 6.6 | $28M | 690k | 40.66 | |
| Auxilium Pharmaceuticals | 6.1 | $26M | 1.3M | 20.73 | |
| Volcano Corporation | 6.1 | $26M | 1.2M | 21.85 | |
| Spectranetics Corporation | 4.6 | $19M | 770k | 25.00 | |
| CareFusion Corporation | 4.3 | $18M | 460k | 39.82 | |
| Greatbatch | 4.2 | $18M | 400k | 44.24 | |
| AtriCure (ATRC) | 3.7 | $16M | 842k | 18.68 | |
| Allergan | 3.3 | $14M | 125k | 111.08 | |
| Covidien | 3.1 | $13M | 190k | 68.10 | |
| Varian Medical Systems | 3.0 | $13M | 165k | 77.69 | |
| Vocera Communications | 2.8 | $12M | 750k | 15.61 | |
| Dex (DXCM) | 2.6 | $11M | 310k | 35.41 | |
| MiMedx (MDXG) | 2.5 | $11M | 1.2M | 8.74 | |
| Insys Therapeutics | 2.1 | $9.1M | 235k | 38.71 | |
| Health Care REIT | 2.1 | $8.8M | 165k | 53.57 | |
| NxStage Medical | 2.1 | $8.8M | 882k | 10.00 | |
| BioMed Realty Trust | 1.9 | $8.2M | 450k | 18.12 | |
| RTI Biologics | 1.4 | $6.1M | 1.7M | 3.54 | |
| Streamline Health Solutions | 1.3 | $5.5M | 794k | 6.98 | |
| Oxford Immunotec Global | 1.3 | $5.3M | 275k | 19.38 | |
| Catamaran | 1.1 | $4.7M | 100k | 47.46 | |
| Pacira Pharmaceuticals (PCRX) | 1.0 | $4.3M | 75k | 57.49 | |
| Luminex Corporation | 0.9 | $3.9M | 199k | 19.40 | |
| BioScrip | 0.9 | $3.7M | 500k | 7.40 | |
| CONMED Corporation (CNMD) | 0.6 | $2.4M | 56k | 42.49 | |
| Discovery Laboratories | 0.1 | $554k | 246k | 2.25 | |
| OraSure Technologies (OSUR) | 0.1 | $377k | 60k | 6.29 |
